<qa>  What is NATALIZUMABs TYSABRI?A PROSPECTIVE, OPEN-LABEL, NON-RANDOMIZED, CLINICAL TRIAL TO DETERMINE IF NATALIZUMAB TYSABRI IMPROVES AMBULATORY MEASURES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS RRMS PATIENTS: 